Current Opinion in HIV and AIDS

Papers
(The H4-Index of Current Opinion in HIV and AIDS is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
New latency-promoting agents for a block-and-lock functional cure strategy960115767
The interplay between HIV and COVID-19: summary of the data and responses to date122
What constitutes a syndemic? Methods, contexts, and framing from 201954
Lenacapavir: a first-in-class HIV-1 capsid inhibitor53
Polypharmacy in HIV: recent insights and future directions42
Ending the HIV epidemic for all, not just some: structural racism as a fundamental but overlooked social-structural determinant of the US HIV epidemic35
Eliminating HIV reservoirs for a cure: the issue is in the tissue33
Multimorbidity patterns in people with HIV31
A new paradigm for antiretroviral delivery: long-acting cabotegravir and rilpivirine for the treatment and prevention of HIV29
Impact of Integrase inhibitors and tenofovir alafenamide on weight gain in people with HIV27
What lessons it might teach us? Community engagement in HIV research24
Hitting the sweet spot: exploiting HIV-1 glycan shield for induction of broadly neutralizing antibodies22
Frailty: the current challenge for aging people with HIV22
Exosomes in HIV infection22
Promise, perils and cautious optimism: the next frontier in long-acting modalities for the treatment and prevention of HIV19
The first 6 months of HIV-SARS-CoV-2 coinfection: outcomes for 6947 individuals18
Cardiovascular toxicity of contemporary antiretroviral therapy17
Broadly neutralizing antibodies combined with latency-reversing agents or immune modulators as strategy for HIV-1 remission17
Syndemic theory, structural violence and HIV among African–Americans17
0.019099950790405